Check our July issue! This month's cover features the article “Sex and ethnic disparities in hepatitis B evaluation and treatment across the world” by Sahith K., Daniel Q. Huang et al. (https://bit.ly/4c80VHo) Full issue here: https://bit.ly/2LXwYxk EASL | The Home of Hepatology
Very interesting...
🩺 What is Hepatomegaly? Understanding Enlarged Liver and Its Causes 🧠 Hepatomegaly, or an enlarged liver, can be a sign of various underlying health conditions. In my latest YouTube video, I explore what hepatomegaly is, its potential causes, and what it means for your liver health. In this video, you'll learn: What is Hepatomegaly?: A clear explanation of what it means when the liver is enlarged and how it’s detected. Common Causes: A deep dive into the various conditions that can lead to hepatomegaly, including liver diseases, heart conditions, and metabolic disorders. Symptoms and Diagnosis: How to recognize the signs of hepatomegaly and the diagnostic tests used to identify its underlying cause. Clinical Relevance: The importance of understanding hepatomegaly in the context of overall liver health and its implications for treatment. Whether you’re a healthcare professional, a student, or someone concerned about liver health, this video provides essential insights into hepatomegaly. 🎥 Watch now: https://lnkd.in/d-ycikyu Stay informed about liver health and its impact on overall well-being! #Hepatomegaly #LiverHealth #MedicalEducation #NoviceMedic #FellowMedics #Healthcare #Hepatology #DoctorLife #LiverDisease #Gastroenterology #MedicalStudents #YouTubeLearning #ClinicalSkills #LiverFunction #HealthAwareness
Giroctocogene fitelparvovec achieved non-inferiority and superiority for the total annualized bleeding rate (ABR) compared to routine Factor VIII (FVIII) replacement prophylaxis treatment from week 12 through at least 15 months, according to data from the AFFINE study (NCT04370054). Learn more: https://bit.ly/3YDjFLl
🚨Don't miss this recent article from Colapietro et al. (Journal of Hepatology, 2023, EASL | The Home of Hepatology) on the incidence & predictors #HCC in pts with autoimmune #hepatitis (AIH) ✅ HCC incidence in patients with AIH is low even after development of cirrhosis ✅ The risk of HCC development in AIH is associated with obesity, cirrhosis, and AIH/PSC variant syndrome at AIH diagnosis ✅ and more.. Read the full research article here👇 https://ow.ly/HOW350Qp4NN
Celebrating my first publication, which has been published in the Journal of Thrombosis and Haemostasis (JTH)! In this study, we evaluated the risk of recurrent venous thromboembolism in premenopausal women using hormonal contraceptives. You can find the article here: https://lnkd.in/eNK64bKe
During the 2022 International Conference of Human Milk Science and Innovation (#ICHMSI) Dr Heidi Karpen shared the impacts of an #exclusivehumanmilkdiet in #neonates with congenital gastrointestinal disorders. Watch her full presentation here: https://hubs.li/Q02dChHr0
Editor in Chief @ Mediterranean Journal of Hematology and Infectious Diseases | Leading Hematology Scholar
Thalidomide is a therapeutic option for patients with β-thalassemia by increasing fetal hemoglobin and thereby reducing the requirement for blood transfusions. However, information on changes in erythropoiesis and iron homeostasis during thalidomide treatment is lacking. This study investigated the effects of thalidomide treatment on hematologic, erythropoietic, and iron-status parameters in patients with transfusion-dependent β-thalassemia (TDT). #sitehttps://lnkd.in/dzBi3wXT
A microbe-mediated brain-gut pathway that could be therapeutically targeted for stress-driven gut-brain comorbidities https://lnkd.in/dFSyCmV2
Associate Dean for Oncologic Sciences, Warren Alpert Medical School, Brown University, Providence, RI
Selective regulation of chemosensitivity in glioblastoma by phosphatidylinositol 3-kinase beta https://lnkd.in/eyscwD3f
Consultant Clinical Biochemist, Joint Clinical Lead at NHSE Getting it Right First Time (GIRFT), Pathology. Laboratory Director Clinical Biochemistry & Clinical Lead for POCT at Lancashire Teaching Hospital @Martin1Myers
In order to use the calculations for AKI Alerts (Acute Kindey Injury), eGFR and KFRE (Kidney Failure Risk Equation) there is a requirement to use Enzymatic methods for creatinine (NICE NG203, and others). However just over 30% of UK laboratories still use the outdated Jaffe colourimetrimetric assay. It is GIRFT’s target to ensure that all English Pathology Departments in England use the enzymatic method by the end of 2024; many countries have already converted. @NHSGIRFT Pathology are working with @UKNEQAS to facilitate the conversion. We are speaking to manufacturers and labs to meet the 2024 creatinine challenge. We ask that pathology laboratories prepare for local conversion through internal discussion and discussion with their suppliers. https://lnkd.in/egH__Zdi https://lnkd.in/eU97QGa9 https://lnkd.in/eQ66xe6r
Cascade screening of first-degree relatives of individuals with high lipoprotein(a) levels, if implemented at scale, is likely to identify a substantial number of additional high-risk individuals. https://ja.ma/3Rie7jX
Médico Infectologista e Hepatologista
2moAlthough the hepatitis B vaccine has been licensed since 1982, hepatitis B virus infection is still a global public health problem.